Literature DB >> 7426931

Progress in the use of iodine therapy for tumours of the eye.

R Sealy, E Buret, H Cleminshaw, C Stannard, E Hering, D Shackleton, J Korrubel, P L le Roux, D Sevel, M van Oldenborgh, J van Selm.   

Abstract

Developments in a new system of brachytherapy for tumours of the eye are reported. This involves the use of 125I sources with special screens and filters to avoid irradiation of vital structures and to produce a homogeneous radiation field. Methods for the treatment of tumours of the lids, conjunctiva, retina, choroid and lachrymal gland have been developed. Sixteen out of 20 treatments appear to have been successful. This system would seem to be a material advance on those previously reported.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426931     DOI: 10.1259/0007-1285-53-635-1052

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  5 in total

1.  Improved iodine-125 plaque design in the treatment of choroidal malignant melanoma.

Authors:  J C Hill; R Sealy; D Shackleton; C Stannard; J Korrubel; E Hering; C Loxton
Journal:  Br J Ophthalmol       Date:  1992-02       Impact factor: 4.638

2.  Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastoma.

Authors:  Jasmine H Francis; Christopher A Barker; Suzanne L Wolden; Beryl McCormick; Kira Segal; Gil Cohen; Y Pierre Gobin; Brian P Marr; Scott E Brodie; Ira J Dunkel; David H Abramson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-08-14       Impact factor: 7.038

3.  Microwave plaque thermoradiotherapy for choroidal melanoma.

Authors:  P T Finger
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

4.  Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma.

Authors:  Andrea Russo; Michela Laguardia; Bertil Damato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-23       Impact factor: 3.117

5.  DNA cell cycle studies in uveal melanoma.

Authors:  D H Char
Journal:  Trans Am Ophthalmol Soc       Date:  1988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.